TEVOGEN BIO HOLDINGS INC. - COMMON STOCK

Tevogen Bio Founder and CEO Dr. Ryan Saadi Named to 2025 NJBIZ Power 100, Celebrating Innovation and Leadership in Accessible T Cell Therapy

28 Feb 2025 10:17:46 By Nasdaq GlobeNewswire

Tevogen Bio’s First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-Owned

21 Feb 2025 12:28:56 By Nasdaq GlobeNewswire

Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision

14 Feb 2025 15:31:40 By Nasdaq GlobeNewswire

Tevogen Bio Shares 2024 Financing Activity on One Year Anniversary of Becoming a Publicly Listed Company; Highlights Operational Efficiency

14 Feb 2025 10:16:54 By Nasdaq GlobeNewswire

Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nation’s Health and Prosperity

14 Feb 2025 08:52:04 By Nasdaq GlobeNewswire

Tevogen Bio CEO Congratulates RFK Jr. on His Confirmation as Secretary of the HHS; Echoes Commitment to Innovation and Affordability for Americans

13 Feb 2025 13:34:10 By Nasdaq GlobeNewswire

Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation

10 Feb 2025 14:30:20 By Nasdaq GlobeNewswire

Tevogen Bio Meets BARDA TechWatch Team, Highlighting ExacTcell™ Technology’s Potential as a Scalable Medical Countermeasure

07 Feb 2025 11:56:54 By Nasdaq GlobeNewswire

Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant Funding

28 Jan 2025 12:49:48 By Nasdaq GlobeNewswire

Tevogen Bio CEO Congratulates Lynne Patton on Being Appointed Deputy Assistant to the President and Director of Minority Outreach

27 Jan 2025 11:24:33 By Nasdaq GlobeNewswire

Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure

24 Jan 2025 14:34:26 By Nasdaq GlobeNewswire

Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference

23 Jan 2025 16:53:05 By Nasdaq GlobeNewswire

Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare Conference

26 Dec 2024 09:21:56 By Nasdaq GlobeNewswire

Tevogen Bio to Host Panel "AI In Biopharma: Next Frontier of Medical Innovation" During the 43rd Annual J.P. Morgan Healthcare Conference

23 Dec 2024 06:38:33 By Nasdaq GlobeNewswire

Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda

19 Dec 2024 05:30:00 By Nasdaq GlobeNewswire

Tevogen Bio to Host Panel “Pioneering the Economics of Health: Balancing Access and Outcomes” During the 43rd Annual J.P. Morgan Healthcare Conference

17 Dec 2024 10:32:20 By Nasdaq GlobeNewswire

Tevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare Conference

10 Dec 2024 12:13:52 By Nasdaq GlobeNewswire

Dr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of Fame

05 Dec 2024 08:03:20 By Nasdaq GlobeNewswire

Tevogen Bio Prepares Organizational Readiness to Support Company’s Growth Strategy

26 Nov 2024 05:05:00 By Nasdaq GlobeNewswire

Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value

21 Nov 2024 12:59:43 By Nasdaq GlobeNewswire